Global Leukemia Targeted Therapy Drugs Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Leukemia Targeted Therapy Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 Monoclonal Antibodies
  • 1.2.3 Small-Molecule Drugs
• 1.3 Market by Application
  • 1.3.1 Global Leukemia Targeted Therapy Drugs Market Share by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Acute Myeloid Leukemia (AML)
  • 1.3.3 Chronic Myeloid Leukemia (CML)
  • 1.3.4 Acute Lymphoblastic Leukemia (ALL)
  • 1.3.5 Chronic Lymphocytic Leukemia (CLL)
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Leukemia Targeted Therapy Drugs Market Perspective (2019-2030)
• 2.2 Global Leukemia Targeted Therapy Drugs Growth Trends by Region
  • 2.2.1 Global Leukemia Targeted Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Leukemia Targeted Therapy Drugs Historic Market Size by Region (2019-2024)
  • 2.2.3 Leukemia Targeted Therapy Drugs Forecasted Market Size by Region (2025-2030)
• 2.3 Leukemia Targeted Therapy Drugs Market Dynamics
  • 2.3.1 Leukemia Targeted Therapy Drugs Industry Trends
  • 2.3.2 Leukemia Targeted Therapy Drugs Market Drivers
  • 2.3.3 Leukemia Targeted Therapy Drugs Market Challenges
  • 2.3.4 Leukemia Targeted Therapy Drugs Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Leukemia Targeted Therapy Drugs by Players
  • 3.1.1 Global Leukemia Targeted Therapy Drugs Revenue by Players (2019-2024)
  • 3.1.2 Global Leukemia Targeted Therapy Drugs Revenue Market Share by Players (2019-2024)
• 3.2 Global Leukemia Targeted Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Leukemia Targeted Therapy Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global Leukemia Targeted Therapy Drugs Market Concentration Ratio
  • 3.4.1 Global Leukemia Targeted Therapy Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Leukemia Targeted Therapy Drugs Revenue in 2023
• 3.5 Global Key Players of Leukemia Targeted Therapy Drugs Head office and Area Served
• 3.6 Global Key Players of Leukemia Targeted Therapy Drugs, Product and Application
• 3.7 Global Key Players of Leukemia Targeted Therapy Drugs, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Leukemia Targeted Therapy Drugs Breakdown Data by Type

• 4.1 Global Leukemia Targeted Therapy Drugs Historic Market Size by Type (2019-2024)
• 4.2 Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Type (2025-2030)

5 Leukemia Targeted Therapy Drugs Breakdown Data by Application

• 5.1 Global Leukemia Targeted Therapy Drugs Historic Market Size by Application (2019-2024)
• 5.2 Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America Leukemia Targeted Therapy Drugs Market Size (2019-2030)
• 6.2 North America Leukemia Targeted Therapy Drugs Market Size by Type
  • 6.2.1 North America Leukemia Targeted Therapy Drugs Market Size by Type (2019-2024)
  • 6.2.2 North America Leukemia Targeted Therapy Drugs Market Size by Type (2025-2030)
  • 6.2.3 North America Leukemia Targeted Therapy Drugs Market Share by Type (2019-2030)
• 6.3 North America Leukemia Targeted Therapy Drugs Market Size by Application
  • 6.3.1 North America Leukemia Targeted Therapy Drugs Market Size by Application (2019-2024)
  • 6.3.2 North America Leukemia Targeted Therapy Drugs Market Size by Application (2025-2030)
  • 6.3.3 North America Leukemia Targeted Therapy Drugs Market Share by Application (2019-2030)
• 6.4 North America Leukemia Targeted Therapy Drugs Market Size by Country
  • 6.4.1 North America Leukemia Targeted Therapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America Leukemia Targeted Therapy Drugs Market Size by Country (2019-2024)
  • 6.4.3 North America Leukemia Targeted Therapy Drugs Market Share by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe Leukemia Targeted Therapy Drugs Market Size (2019-2030)
• 7.2 Europe Leukemia Targeted Therapy Drugs Market Size by Type
  • 7.2.1 Europe Leukemia Targeted Therapy Drugs Market Size by Type (2019-2024)
  • 7.2.2 Europe Leukemia Targeted Therapy Drugs Market Size by Type (2025-2030)
  • 7.2.3 Europe Leukemia Targeted Therapy Drugs Market Share by Type (2019-2030)
• 7.3 Europe Leukemia Targeted Therapy Drugs Market Size by Application
  • 7.3.1 Europe Leukemia Targeted Therapy Drugs Market Size by Application (2019-2024)
  • 7.3.2 Europe Leukemia Targeted Therapy Drugs Market Size by Application (2025-2030)
  • 7.3.3 Europe Leukemia Targeted Therapy Drugs Market Share by Application (2019-2030)
• 7.4 Europe Leukemia Targeted Therapy Drugs Market Size by Country
  • 7.4.1 Europe Leukemia Targeted Therapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe Leukemia Targeted Therapy Drugs Market Size by Country (2019-2024)
  • 7.4.3 Europe Leukemia Targeted Therapy Drugs Market Size by Country (2025-2030)
  • 7.4.4 Germany
  • 7.4.5 France
  • 7.4.6 U.K.
  • 7.4.7 Italy
  • 7.4.8 Russia
  • 7.4.9 Nordic Countries

8 China

• 8.1 China Leukemia Targeted Therapy Drugs Market Size (2019-2030)
• 8.2 China Leukemia Targeted Therapy Drugs Market Size by Type
  • 8.2.1 China Leukemia Targeted Therapy Drugs Market Size by Type (2019-2024)
  • 8.2.2 China Leukemia Targeted Therapy Drugs Market Size by Type (2025-2030)
  • 8.2.3 China Leukemia Targeted Therapy Drugs Market Share by Type (2019-2030)
• 8.3 China Leukemia Targeted Therapy Drugs Market Size by Application
  • 8.3.1 China Leukemia Targeted Therapy Drugs Market Size by Application (2019-2024)
  • 8.3.2 China Leukemia Targeted Therapy Drugs Market Size by Application (2025-2030)
  • 8.3.3 China Leukemia Targeted Therapy Drugs Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Leukemia Targeted Therapy Drugs Market Size (2019-2030)
• 9.2 Asia Leukemia Targeted Therapy Drugs Market Size by Type
  • 9.2.1 Asia Leukemia Targeted Therapy Drugs Market Size by Type (2019-2024)
  • 9.2.2 Asia Leukemia Targeted Therapy Drugs Market Size by Type (2025-2030)
  • 9.2.3 Asia Leukemia Targeted Therapy Drugs Market Share by Type (2019-2030)
• 9.3 Asia Leukemia Targeted Therapy Drugs Market Size by Application
  • 9.3.1 Asia Leukemia Targeted Therapy Drugs Market Size by Application (2019-2024)
  • 9.3.2 Asia Leukemia Targeted Therapy Drugs Market Size by Application (2025-2030)
  • 9.3.3 Asia Leukemia Targeted Therapy Drugs Market Share by Application (2019-2030)
• 9.4 Asia Leukemia Targeted Therapy Drugs Market Size by Region
  • 9.4.1 Asia Leukemia Targeted Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia Leukemia Targeted Therapy Drugs Market Size by Region (2019-2024)
  • 9.4.3 Asia Leukemia Targeted Therapy Drugs Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 Novartis Pharms
  • 11.1.1 Novartis Pharms Company Details
  • 11.1.2 Novartis Pharms Business Overview
  • 11.1.3 Novartis Pharms Leukemia Targeted Therapy Drugs Introduction
  • 11.1.4 Novartis Pharms Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.1.5 Novartis Pharms Recent Development
• 11.2 Bristol-Myers Squibb
  • 11.2.1 Bristol-Myers Squibb Company Details
  • 11.2.2 Bristol-Myers Squibb Business Overview
  • 11.2.3 Bristol-Myers Squibb Leukemia Targeted Therapy Drugs Introduction
  • 11.2.4 Bristol-Myers Squibb Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.2.5 Bristol-Myers Squibb Recent Development
• 11.3 IL-Yang Pharms
  • 11.3.1 IL-Yang Pharms Company Details
  • 11.3.2 IL-Yang Pharms Business Overview
  • 11.3.3 IL-Yang Pharms Leukemia Targeted Therapy Drugs Introduction
  • 11.3.4 IL-Yang Pharms Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.3.5 IL-Yang Pharms Recent Development
• 11.4 Pfizer
  • 11.4.1 Pfizer Company Details
  • 11.4.2 Pfizer Business Overview
  • 11.4.3 Pfizer Leukemia Targeted Therapy Drugs Introduction
  • 11.4.4 Pfizer Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.4.5 Pfizer Recent Development
• 11.5 Takeda Oncology
  • 11.5.1 Takeda Oncology Company Details
  • 11.5.2 Takeda Oncology Business Overview
  • 11.5.3 Takeda Oncology Leukemia Targeted Therapy Drugs Introduction
  • 11.5.4 Takeda Oncology Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.5.5 Takeda Oncology Recent Development
• 11.6 Johnson & Johnson
  • 11.6.1 Johnson & Johnson Company Details
  • 11.6.2 Johnson & Johnson Business Overview
  • 11.6.3 Johnson & Johnson Leukemia Targeted Therapy Drugs Introduction
  • 11.6.4 Johnson & Johnson Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.6.5 Johnson & Johnson Recent Development
• 11.7 Gilead Sciences
  • 11.7.1 Gilead Sciences Company Details
  • 11.7.2 Gilead Sciences Business Overview
  • 11.7.3 Gilead Sciences Leukemia Targeted Therapy Drugs Introduction
  • 11.7.4 Gilead Sciences Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.7.5 Gilead Sciences Recent Development
• 11.8 Abbvie
  • 11.8.1 Abbvie Company Details
  • 11.8.2 Abbvie Business Overview
  • 11.8.3 Abbvie Leukemia Targeted Therapy Drugs Introduction
  • 11.8.4 Abbvie Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.8.5 Abbvie Recent Development
• 11.9 Genentech
  • 11.9.1 Genentech Company Details
  • 11.9.2 Genentech Business Overview
  • 11.9.3 Genentech Leukemia Targeted Therapy Drugs Introduction
  • 11.9.4 Genentech Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.9.5 Genentech Recent Development
• 11.10 Sanofi
  • 11.10.1 Sanofi Company Details
  • 11.10.2 Sanofi Business Overview
  • 11.10.3 Sanofi Leukemia Targeted Therapy Drugs Introduction
  • 11.10.4 Sanofi Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.10.5 Sanofi Recent Development
• 11.11 Amgen
  • 11.11.1 Amgen Company Details
  • 11.11.2 Amgen Business Overview
  • 11.11.3 Amgen Leukemia Targeted Therapy Drugs Introduction
  • 11.11.4 Amgen Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.11.5 Amgen Recent Development
• 11.12 Roche
  • 11.12.1 Roche Company Details
  • 11.12.2 Roche Business Overview
  • 11.12.3 Roche Leukemia Targeted Therapy Drugs Introduction
  • 11.12.4 Roche Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.12.5 Roche Recent Development
• 11.13 GlaxoSmithKline
  • 11.13.1 GlaxoSmithKline Company Details
  • 11.13.2 GlaxoSmithKline Business Overview
  • 11.13.3 GlaxoSmithKline Leukemia Targeted Therapy Drugs Introduction
  • 11.13.4 GlaxoSmithKline Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.13.5 GlaxoSmithKline Recent Development
• 11.14 AstraZeneca
  • 11.14.1 AstraZeneca Company Details
  • 11.14.2 AstraZeneca Business Overview
  • 11.14.3 AstraZeneca Leukemia Targeted Therapy Drugs Introduction
  • 11.14.4 AstraZeneca Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.14.5 AstraZeneca Recent Development
• 11.15 BeiGene
  • 11.15.1 BeiGene Company Details
  • 11.15.2 BeiGene Business Overview
  • 11.15.3 BeiGene Leukemia Targeted Therapy Drugs Introduction
  • 11.15.4 BeiGene Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.15.5 BeiGene Recent Development
• 11.16 Eli Lilly
  • 11.16.1 Eli Lilly Company Details
  • 11.16.2 Eli Lilly Business Overview
  • 11.16.3 Eli Lilly Leukemia Targeted Therapy Drugs Introduction
  • 11.16.4 Eli Lilly Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.16.5 Eli Lilly Recent Development
• 11.17 Merck
  • 11.17.1 Merck Company Details
  • 11.17.2 Merck Business Overview
  • 11.17.3 Merck Leukemia Targeted Therapy Drugs Introduction
  • 11.17.4 Merck Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)
  • 11.17.5 Merck Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global Leukemia Targeted Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Small-Molecule Drugs

Table 4. Global Leukemia Targeted Therapy Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Leukemia Targeted Therapy Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Leukemia Targeted Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Leukemia Targeted Therapy Drugs Market Share by Region (2019-2024)

Table 8. Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Leukemia Targeted Therapy Drugs Market Share by Region (2025-2030)

Table 10. Leukemia Targeted Therapy Drugs Market Trends

Table 11. Leukemia Targeted Therapy Drugs Market Drivers

Table 12. Leukemia Targeted Therapy Drugs Market Challenges

Table 13. Leukemia Targeted Therapy Drugs Market Restraints

Table 14. Global Leukemia Targeted Therapy Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Leukemia Targeted Therapy Drugs Market Share by Players (2019-2024)

Table 16. Global Top Leukemia Targeted Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Targeted Therapy Drugs as of 2023)

Table 17. Global Leukemia Targeted Therapy Drugs Industry Ranking 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Leukemia Targeted Therapy Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Leukemia Targeted Therapy Drugs, Headquarters and Area Served

Table 20. Global Key Players of Leukemia Targeted Therapy Drugs, Product and Application

Table 21. Global Key Players of Leukemia Targeted Therapy Drugs, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Leukemia Targeted Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Type (2019-2024)

Table 25. Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Type (2025-2030)

Table 27. Global Leukemia Targeted Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Application (2019-2024)

Table 29. Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Application (2025-2030)

Table 31. North America Leukemia Targeted Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Leukemia Targeted Therapy Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Leukemia Targeted Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Leukemia Targeted Therapy Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Leukemia Targeted Therapy Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Leukemia Targeted Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Leukemia Targeted Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Leukemia Targeted Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Leukemia Targeted Therapy Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Leukemia Targeted Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Leukemia Targeted Therapy Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Leukemia Targeted Therapy Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Leukemia Targeted Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Leukemia Targeted Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Leukemia Targeted Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Leukemia Targeted Therapy Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Leukemia Targeted Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Leukemia Targeted Therapy Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Leukemia Targeted Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Leukemia Targeted Therapy Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Leukemia Targeted Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Leukemia Targeted Therapy Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Leukemia Targeted Therapy Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Leukemia Targeted Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Leukemia Targeted Therapy Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 63. Novartis Pharms Company Details

Table 64. Novartis Pharms Business Overview

Table 65. Novartis Pharms Leukemia Targeted Therapy Drugs Product

Table 66. Novartis Pharms Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 67. Novartis Pharms Recent Development

Table 68. Bristol-Myers Squibb Company Details

Table 69. Bristol-Myers Squibb Business Overview

Table 70. Bristol-Myers Squibb Leukemia Targeted Therapy Drugs Product

Table 71. Bristol-Myers Squibb Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 72. Bristol-Myers Squibb Recent Development

Table 73. IL-Yang Pharms Company Details

Table 74. IL-Yang Pharms Business Overview

Table 75. IL-Yang Pharms Leukemia Targeted Therapy Drugs Product

Table 76. IL-Yang Pharms Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 77. IL-Yang Pharms Recent Development

Table 78. Pfizer Company Details

Table 79. Pfizer Business Overview

Table 80. Pfizer Leukemia Targeted Therapy Drugs Product

Table 81. Pfizer Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 82. Pfizer Recent Development

Table 83. Takeda Oncology Company Details

Table 84. Takeda Oncology Business Overview

Table 85. Takeda Oncology Leukemia Targeted Therapy Drugs Product

Table 86. Takeda Oncology Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 87. Takeda Oncology Recent Development

Table 88. Johnson & Johnson Company Details

Table 89. Johnson & Johnson Business Overview

Table 90. Johnson & Johnson Leukemia Targeted Therapy Drugs Product

Table 91. Johnson & Johnson Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 92. Johnson & Johnson Recent Development

Table 93. Gilead Sciences Company Details

Table 94. Gilead Sciences Business Overview

Table 95. Gilead Sciences Leukemia Targeted Therapy Drugs Product

Table 96. Gilead Sciences Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 97. Gilead Sciences Recent Development

Table 98. Abbvie Company Details

Table 99. Abbvie Business Overview

Table 100. Abbvie Leukemia Targeted Therapy Drugs Product

Table 101. Abbvie Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 102. Abbvie Recent Development

Table 103. Genentech Company Details

Table 104. Genentech Business Overview

Table 105. Genentech Leukemia Targeted Therapy Drugs Product

Table 106. Genentech Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 107. Genentech Recent Development

Table 108. Sanofi Company Details

Table 109. Sanofi Business Overview

Table 110. Sanofi Leukemia Targeted Therapy Drugs Product

Table 111. Sanofi Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 112. Sanofi Recent Development

Table 113. Amgen Company Details

Table 114. Amgen Business Overview

Table 115. Amgen Leukemia Targeted Therapy Drugs Product

Table 116. Amgen Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 117. Amgen Recent Development

Table 118. Roche Company Details

Table 119. Roche Business Overview

Table 120. Roche Leukemia Targeted Therapy Drugs Product

Table 121. Roche Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 122. Roche Recent Development

Table 123. GlaxoSmithKline Company Details

Table 124. GlaxoSmithKline Business Overview

Table 125. GlaxoSmithKline Leukemia Targeted Therapy Drugs Product

Table 126. GlaxoSmithKline Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 127. GlaxoSmithKline Recent Development

Table 128. AstraZeneca Company Details

Table 129. AstraZeneca Business Overview

Table 130. AstraZeneca Leukemia Targeted Therapy Drugs Product

Table 131. AstraZeneca Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 132. AstraZeneca Recent Development

Table 133. BeiGene Company Details

Table 134. BeiGene Business Overview

Table 135. BeiGene Leukemia Targeted Therapy Drugs Product

Table 136. BeiGene Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 137. BeiGene Recent Development

Table 138. Eli Lilly Company Details

Table 139. Eli Lilly Business Overview

Table 140. Eli Lilly Leukemia Targeted Therapy Drugs Product

Table 141. Eli Lilly Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 142. Eli Lilly Recent Development

Table 143. Merck Company Details

Table 144. Merck Business Overview

Table 145. Merck Leukemia Targeted Therapy Drugs Product

Table 146. Merck Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 147. Merck Recent Development

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Leukemia Targeted Therapy Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Leukemia Targeted Therapy Drugs Market Share by Type: 2023 VS 2030

Figure 3. Monoclonal Antibodies Features

Figure 4. Small-Molecule Drugs Features

Figure 5. Global Leukemia Targeted Therapy Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Leukemia Targeted Therapy Drugs Market Share by Application: 2023 VS 2030

Figure 7. Acute Myeloid Leukemia (AML) Case Studies

Figure 8. Chronic Myeloid Leukemia (CML) Case Studies

Figure 9. Acute Lymphoblastic Leukemia (ALL) Case Studies

Figure 10. Chronic Lymphocytic Leukemia (CLL) Case Studies

Figure 11. Leukemia Targeted Therapy Drugs Report Years Considered

Figure 12. Global Leukemia Targeted Therapy Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Leukemia Targeted Therapy Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Leukemia Targeted Therapy Drugs Market Share by Region: 2023 VS 2030

Figure 15. Global Leukemia Targeted Therapy Drugs Market Share by Players in 2023

Figure 16. Global Top Leukemia Targeted Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Targeted Therapy Drugs as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Leukemia Targeted Therapy Drugs Revenue in 2023

Figure 18. North America Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Leukemia Targeted Therapy Drugs Market Share by Type (2019-2030)

Figure 20. North America Leukemia Targeted Therapy Drugs Market Share by Application (2019-2030)

Figure 21. North America Leukemia Targeted Therapy Drugs Market Share by Country (2019-2030)

Figure 22. United States Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Leukemia Targeted Therapy Drugs Market Share by Type (2019-2030)

Figure 26. Europe Leukemia Targeted Therapy Drugs Market Share by Application (2019-2030)

Figure 27. Europe Leukemia Targeted Therapy Drugs Market Share by Country (2019-2030)

Figure 28. Germany Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Leukemia Targeted Therapy Drugs Market Share by Type (2019-2030)

Figure 36. China Leukemia Targeted Therapy Drugs Market Share by Application (2019-2030)

Figure 37. Asia Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Asia Leukemia Targeted Therapy Drugs Market Share by Type (2019-2030)

Figure 39. Asia Leukemia Targeted Therapy Drugs Market Share by Application (2019-2030)

Figure 40. Asia Leukemia Targeted Therapy Drugs Market Share by Region (2019-2030)

Figure 41. Japan Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Leukemia Targeted Therapy Drugs Market Share by Country (2019-2030)

Figure 51. Brazil Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Novartis Pharms Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 59. IL-Yang Pharms Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 60. Pfizer Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 61. Takeda Oncology Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 62. Johnson & Johnson Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 63. Gilead Sciences Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 64. Abbvie Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 65. Genentech Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 66. Sanofi Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 67. Amgen Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 68. Roche Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 69. GlaxoSmithKline Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 70. AstraZeneca Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 71. BeiGene Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 72. Eli Lilly Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 73. Merck Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed